Citigroup’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.6M | Buy |
1,045,000
+750,000
| +254% | +$60M | 0.03% | 542 |
|
|
2025
Q4 | $28.1M | Sell |
295,000
-609,900
| -67% | -$59.8M | 0.01% | 918 |
|
|
2025
Q3 | $88.3M | Buy |
904,900
+817,600
| +937% | +$84.7M | 0.04% | 419 |
|
|
2025
Q2 | $9.38M | Sell |
87,300
-343,700
| -80% | -$34.8M | ﹤0.01% | 1418 |
|
|
2025
Q1 | $43.5M | Sell |
431,000
-85,000
| -16% | -$8.56M | 0.02% | 598 |
|
|
2024
Q4 | $46.1M | Sell |
516,000
-4,100
| -0.8% | -$361K | 0.03% | 554 |
|
|
2024
Q3 | $43.6M | Buy |
520,100
+134,000
| +35% | +$10.6M | 0.03% | 592 |
|
|
2024
Q2 | $29.7M | Buy |
386,100
+194,100
| +101% | +$14.2M | 0.02% | 714 |
|
|
2024
Q1 | $13.2M | Sell |
192,000
-30,000
| -14% | -$1.93M | 0.01% | 1097 |
|
|
2023
Q4 | $12.8M | Buy |
222,000
+140,000
| +171% | +$7.47M | 0.01% | 1091 |
|
|
2023
Q3 | $4.33M | Buy |
82,000
+17,000
| +26% | +$892K | ﹤0.01% | 1516 |
|
|
2023
Q2 | $3.52M | Buy |
65,000
+35,000
| +117% | +$1.83M | ﹤0.01% | 1736 |
|
|
2023
Q1 | $1.5M | Buy |
+30,000
| New | +$1.41M | ﹤0.01% | 2217 |
|
|
2022
Q3 | – | Sell |
-250,000
| Closed | -$9.32M | – | 5853 |
|
|
2022
Q2 | $9.32M | Buy |
250,000
+96,800
| +63% | +$3.94M | 0.01% | 1190 |
|
|
2022
Q1 | $6.79M | Sell |
153,200
-355,800
| -70% | -$15.4M | ﹤0.01% | 1502 |
|
|
2021
Q4 | $21.6M | Buy |
509,000
+249,000
| +96% | +$10.5M | 0.01% | 967 |
|
|
2021
Q3 | $11.3M | Hold |
260,000
| – | – | 0.01% | 1332 |
|
|
2021
Q2 | $11.1M | Hold |
260,000
| – | – | 0.01% | 1349 |
|
|
2021
Q1 | $10M | Sell |
260,000
-34,300
| -12% | -$1.3M | 0.01% | 1368 |
|
|
2020
Q4 | $10.6M | Buy |
294,300
+31,900
| +12% | +$1.15M | 0.01% | 1506 |
|
|
2020
Q3 | $10M | Buy |
262,400
+104,800
| +66% | +$4.04M | 0.01% | 1373 |
|
|
2020
Q2 | $5.53M | Sell |
157,600
-82,200
| -34% | -$2.96M | ﹤0.01% | 1772 |
|
|
2020
Q1 | $7.83M | Sell |
239,800
-45,500
| -16% | -$1.78M | 0.01% | 1324 |
|
|
2019
Q4 | $12.9M | Sell |
285,300
-17,500
| -6% | -$732K | 0.01% | 1269 |
|
|
2019
Q3 | $12.3M | Buy |
302,800
+214,800
| +244% | +$9.1M | 0.01% | 1248 |
|
|
2019
Q2 | $3.78M | Sell |
88,000
-61,400
| -41% | -$2.36M | ﹤0.01% | 2211 |
|
|
2019
Q1 | $5.73M | Sell |
149,400
-35,400
| -19% | -$1.35M | 0.01% | 1672 |
|
|
2018
Q4 | $6.53M | Sell |
184,800
-221,700
| -55% | -$8.04M | 0.01% | 1599 |
|
|
2018
Q3 | $15.7M | Buy |
406,500
+168,200
| +71% | +$5.87M | 0.01% | 997 |
|
|
2018
Q2 | $7.79M | Buy |
238,300
+109,500
| +85% | +$3.3M | 0.01% | 1467 |
|
|
2018
Q1 | $3.52M | Sell |
128,800
-55,400
| -30% | -$1.51M | ﹤0.01% | 2092 |
|
|
2017
Q4 | $4.57M | Buy |
184,200
+72,700
| +65% | +$2.01M | ﹤0.01% | 1915 |
|
|
2017
Q3 | $3.25M | Buy |
111,500
+48,100
| +76% | +$1.33M | ﹤0.01% | 2156 |
|
|
2017
Q2 | $1.76M | Sell |
63,400
-78,000
| -55% | -$2.07M | ﹤0.01% | 2723 |
|
|
2017
Q1 | $3.52M | Buy |
141,400
+71,800
| +103% | +$1.75M | ﹤0.01% | 1955 |
|
|
2016
Q4 | $1.5M | Sell |
69,600
-14,800
| -18% | -$323K | ﹤0.01% | 3258 |
|
|
2016
Q3 | $2.01M | Buy |
84,400
+35,700
| +73% | +$852K | ﹤0.01% | 2506 |
|
|
2016
Q2 | $1.14M | Sell |
48,700
-55,100
| -53% | -$1.19M | ﹤0.01% | 2830 |
|
|
2016
Q1 | $1.95M | Buy |
103,800
+58,100
| +127% | +$1.02M | ﹤0.01% | 2519 |
|
|
2015
Q4 | $843K | Sell |
45,700
-42,000
| -48% | -$753K | ﹤0.01% | 3330 |
|
|
2015
Q3 | $1.44M | Buy |
87,700
+9,300
| +12% | +$159K | ﹤0.01% | 2745 |
|
|
2015
Q2 | $1.39M | Sell |
78,400
-30,900
| -28% | -$552K | ﹤0.01% | 2878 |
|
|
2015
Q1 | $1.94M | Buy |
109,300
+15,700
| +17% | +$248K | ﹤0.01% | 2504 |
|
|
2014
Q4 | $1.24M | Sell |
93,600
-25,000
| -21% | -$320K | ﹤0.01% | 2920 |
|
|
2014
Q3 | $1.4M | Buy |
118,600
+47,300
| +66% | +$596K | ﹤0.01% | 2804 |
|
|
2014
Q2 | $911K | Sell |
71,300
-103,300
| -59% | -$1.34M | ﹤0.01% | 3032 |
|
|
2014
Q1 | $2.36M | Buy |
174,600
+49,700
| +40% | +$652K | ﹤0.01% | 2243 |
|
|
2013
Q4 | $1.5M | Sell |
124,900
-69,600
| -36% | -$822K | ﹤0.01% | 2828 |
|
|
2013
Q3 | $2.28M | Buy |
194,500
+26,500
| +16% | +$287K | ﹤0.01% | 2369 |
|
|
2013
Q2 | $1.56M | Buy |
+168,000
| New | +$1.43M | ﹤0.01% | 2553 |
|
Other funds holding BSX
VCM
VPM
Citigroup's BSX Position: Q1 2026 in Review
Citigroup increased its Boston Scientific (BSX) stake by 16% in Q1 2026, buying an estimated $17.6M and bringing the position to 1,576,640 shares worth $98.9M. The position accounts for 0.04% of the portfolio, ranked #409.
Citigroup first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $433M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Citigroup held 1,576,640 shares of Boston Scientific worth $98.9M as of Q1 2026.
- Citigroup bought 220,141 Boston Scientific shares in Q1 2026, an estimated $17.6M.
- Boston Scientific made up 0.04% of Citigroup's portfolio in Q1 2026, its #409 holding.
- Citigroup first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Boston Scientific position peaked at $433M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.